Christopher Michael Bull
Nessuna posizione attualmente
Storia della carriera di Christopher Michael Bull
Precedenti posizioni note di Christopher Michael Bull
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AFRICAN DAWN CAPITAL LIMITED | Presidente | 31/10/2014 | 12/06/2015 |
| Independent Dir/Board Member | 31/10/2014 | 12/06/2015 | |
Oxyrane UK Ltd.
 Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Formazione di Christopher Michael Bull
| University of KwaZulu-Natal | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Sud Africa | 3 |
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
| Chairman | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AFRICAN DAWN CAPITAL LIMITED | Finance |
| Aziende private | 1 |
|---|---|
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |
